| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 7.738 | 5.090 | 857 |
| Total Expenses - EUR | - | - | - | - | 328 | 259 | 643 | 9.231 | 7.960 | 1.845 |
| Gross Profit/Loss - EUR | - | - | - | - | -328 | -259 | -643 | -1.493 | -2.870 | -988 |
| Net Profit/Loss - EUR | - | - | - | - | -328 | -259 | -643 | -1.493 | -2.870 | -988 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Europharm Wholesale S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 121 | 0 | 0 | 300.900 | 299.988 | 298.311 |
| Current Assets | - | - | - | - | 214 | 214 | 209 | 325 | 146 | 48 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 4 | 4 | 0 |
| Cash | - | - | - | - | 214 | 214 | 209 | 321 | 142 | 48 |
| Shareholders Funds | - | - | - | - | -115 | -373 | -1.008 | -2.503 | -5.366 | -6.324 |
| Social Capital | - | - | - | - | 213 | 209 | 204 | 205 | 204 | 203 |
| Debts | - | - | - | - | 450 | 587 | 1.217 | 303.729 | 305.500 | 304.683 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6421 - 6421" | |||||||||
| CAEN Financial Year |
6420
|
|||||||||
Comments - Europharm Wholesale S.r.l.